Show/hide main menu

News

News Highlights

Gene could hold key to treating Parkinson's disease

Posted on 19/10/2015
fruitfly-parkinsons-puff

Fruit fly: nerves with damaged mitochondria are highlighted in green

Researchers at King’s College London have identified a new gene linked to nerve function, which could provide a treatment target for ‘switching off’ the gene in people with neurodegenerative diseases such as Parkinson’s disease. 

Parkinson’s disease affects approximately 7-10 million people worldwide and is characterised by progressive loss of motor function, psychiatric symptoms and cognitive impairment. 

Current treatments for Parkinson’s only treat symptoms of the disease rather than its underlying causes, so these new findings in fruit flies could lead to novel preventative treatments if replicated in humans.

Previous research suggests that defects in mitochondria, which are tiny ‘batteries’ in cells that provide energy, play an important role in a number of diseases that affect the nervous system, including Parkinson’s. However, until now the neuronal processes underlying the development of these conditions were unknown.

The study, published today in PNAS, discovered that damaged mitochondria in fruit flies produce a signal which stops nerve cells from working. A gene called HIFalpha was found to regulate the nerve signals from damaged mitochondria and, when this gene was ‘switched off’ by the research team, nerve function in flies with Parkinson’s disease was restored. By deactivating the HIFalpha gene, the early failure of nerve cells caused by mitochondrial damage was prevented. 

An identical effect was observed in flies with Leigh syndrome, a rare neurological disorder caused by a severe mitochondrial defect, which typically arises in the first year of life in humans. 

As the HIFalpha gene is also found in humans, this new finding could pave the way for new treatments in the future, according to the study authors. 

Dr Joseph Bateman from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, said: ‘Like their human counterparts flies with Parkinson’s disease progressively lose motor function, which includes a negative impact on their ability to climb. Remarkably, we found that switching off a particular gene dramatically improved their motor function and climbing ability. 

‘The biggest surprise from our work is that damaged mitochondria produce a signal that actively prevents nerve cells from working properly. Thanks to this study we now have a much better understanding of how nerve cells function, which could transform the way in which neurological diseases such as Parkinson’s are understood and treated.’



Claire Bale, Head of Research Communications at Parkinson’s UK, said: ‘Understanding how subtle changes in our genes may trigger brain cell death is one of the most promising avenues for the development of new treatments for Parkinson’s.

‘This discovery adds a new piece to the intricate jigsaw puzzle of genetic factors that play a part in Parkinson’s.’

This research was carried out in collaboration with Dr Sean Sweeney of the Department of Biology, University of York and Dr Marc Dionne of the Department of Life Sciences, Imperial College London. 

The study was part-funded by the Wellcome Trust, the Biotechnology and Biological Sciences Research Council (BBSRC) and a Biomedical Research Studentship / Fellowship to study co-author Olivia Duncan from the National Institute for Health Research (NIHR) Biomedical Research Centre [and Dementia Unit] at South London and Maudsley NHS Foundation Trust and King's College London.

Notes to editors

Paper reference: Cagin, U et al (2015) Mitochondrial retrograde signalling regulates neuronal function PNAS

For further media information please contact Jack Stonebridge, Press Officer, Institute of Psychiatry, Psychology & Neuroscience, King’s College London on +44 (0) 20 7848 5377 or jack.stonebridge@kcl.ac.uk.

For further information about King’s visit our ‘King’s in Brief’ page.

Rss Feed Atom Feed

News Highlights:

News Highlights...RSS FeedAtom Feed

Treatments offer hope for Chronic Fatigue Syndrome (CFS/ME)

Treatments offer hope for Chronic Fatigue Syndrome (CFS/ME)

Description
Researchers have found that two treatments for Chronic Fatigue Syndrome have long term benefits for people affected by the condition.
Mental health problems likely to increase after troops return from Afghanistan

Mental health problems likely to increase after troops return from Afghanistan

Description
Mental health problems such as post-traumatic stress disorder (PTSD), depression and anxiety are likely to increase in UK military personnel during the months after returning from Afghanistan, according to a study by researchers from King's Centre for Military Health Research (KCMHR) at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London.
First clinical evidence on mental health toll of human trafficking

First clinical evidence on mental health toll of human trafficking

Description
A new study by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London provides the first clinical evidence on the toll human trafficking has on mental health, including high levels of post-traumatic stress disorder (PTSD) and depression, amongst a patient population in South London.

Share this story:

add

Follow Us

@kingscollegelon

Live Twitter feed...

@kingscollegelon
Join the conversation
Sitemap Site help Terms and conditions Privacy policy Accessibility Recruitment News Centre Contact us

© 2016 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454